Enanta Pharmaceuticals Inc (ENTA)

14.64 -0.75%

Enanta Pharmaceuticals Inc (ENTA) is currently trading at $14.64. This represents a loss of 0.75% from the previous session. With a market capitalization of $0.42B, ENTA is a key component of the Health Care sector. Investors looking to trade ENTA should compare margin rates and options platforms to optimize their portfolio management.

Broker Promotion
Claim Your $300 Cash Bonus → T&Cs Apply. Trade ENTA commission-free.
Trading Platform Comparison
Moomoo
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Good for small traders
IBKR
  • Min Deposit: $0
  • Commissions: $0–$0.005/share
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Professional-level tools
Ameritrade
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Strong research tools
Webull
  • Min Deposit: $0
  • Commissions: $0
  • Fractional Shares: ✅
  • Options: ✅
  • Notes: Easy mobile app
AI Market Sentiment

As of today, Enanta Pharmaceuticals Inc (ENTA) shows a bearish trend. Analysts are watching the 15.28 level closely.

Fundamentals
Mkt Cap0.42B
P/E Ratio0.0000
Volume164,494
Others Watching (By Market Cap)
CMPX
Compass Therape $5.89
-1.83% VTYX
Ventyx Bioscien $13.97
+0.07% STAA
STAAR Surgical $20.13
+1.92% CTMX
CytomX Therapeu $5.79
+6.43% PCRX
Pacira Bioscien $23.46
+0.21%
60-Day Technical Chart
Advanced Charting

Need more indicators for ENTA? Use the world's #1 platform.

Open ENTA on TradingView →
Charting Platforms
TradingView

Advanced charts & indicators, web & mobile

StockCharts

Technical analysis charts with overlays & indicators

BarCharts

Market data, charts, and technical signals

Finviz

Visual stock charts & heatmaps

Yahoo Finance Charts

Basic interactive charts with indicators

Side-by-Side: Stocks Near $15
Metric ENTA
-0.75% 		AAL
+1.29% 		HIMS
+2.33% 		LUNR
-15.93%
Price $14.64 $13.32 $15.82 $15.89
Mkt Cap $0.42B $8.80B $3.61B $3.23B
- View → View → View →
Latest Headlines
What Makes Enanta Pharmaceuticals (ENTA) a New Buy Stock Yahoo Finance • Feb 12, 2026 Enanta Pharmaceuticals Reports Financial Results for its Fiscal First Quarter Ended December 31, 2025 Business Wire • Feb 9, 2026 $65 Million Stock Offering: Biotech Enanta Pharmaceuticals Prices 6.5M Shares with Additional Option Stock Titan • Sep 30, 2025 Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA) Stock Catapults 27% Though Its Price And Business Still Lag The Industry simplywall.st • Dec 20, 2025 Enanta shares rise despite RSV trial failing to meet main goal Seeking Alpha • Sep 29, 2025
● Gemini Agentic AI Analyst Insight for ENTA
Market Education
View All Articles →
External Research